-
Je něco špatně v tomto záznamu ?
Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates
L. Micenková, J. Bosák, B. Štaudová, D. Kohoutová, D. Čejková, V. Woznicová, M. Vrba, A. Ševčíková, J. Bureš, D. Šmajs,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2012
Free Medical Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-03-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Medline Complete (EBSCOhost)
od 2014-04-01
Health & Medicine (ProQuest)
od 2012-03-01
Wiley Free Content
od 2012
Wiley-Blackwell Open Access Titles
od 2012
ROAD: Directory of Open Access Scholarly Resources
od 2012
PubMed
26987297
DOI
10.1002/mbo3.345
Knihovny.cz E-zdroje
- MeSH
- bakteriociny metabolismus MeSH
- Escherichia coli klasifikace izolace a purifikace metabolismus patogenita MeSH
- feces mikrobiologie MeSH
- fylogeneze MeSH
- gastrointestinální trakt mikrobiologie MeSH
- koliciny metabolismus MeSH
- lidé MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Escherichia coli strains are classified into four main phylogenetic groups (A, B1, B2, and D) and strains of these phylogroups differ in a number of characteristics. This study tested whether human fecal E. coli isolates belonging to different phylogroups differ in prevalence of bacteriocinogenic isolates and prevalence of individual bacteriocinogenic determinants. A set of 1283 fecal E. coli isolates from patients with different diseases was tested for the presence of DNA regions allowing classification into E. coli phylogroups and for the ability to produce bacteriocins (23 colicins and 7 microcins). Of the isolates tested, the most common was phylogroup B2 (38.3%) followed by phylogroups A (28.3%), D (26.3%) and B1 (7.2%). Altogether, 695 bacteriocin producers were identified representing 54.2% of all tested isolates. The highest prevalence of bacteriocin producers was found in group B2 (60.3%) and the lowest in group B1 (44.6%). Determinants encoding colicins E1, Ia, and microcin mV were most common in phylogroup A, determinants encoding microcins mM and mH47 were most common in phylogroup B2, and determinant encoding mB17 was most common in phylogroup D. The highest prevalence of bacteriocinogeny was found in phylogroup B2, suggesting that bacteriocinogeny and especially the synthesis of microcins was associated with virulent and resident E. coli strains.
Department of Clinical Microbiology Faculty Hospital Brno Jihlavská 20 625 00 Brno Czech Republic
Department of Immunology Veterinary Research Institute Hudcova 70 621 00 Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17024115
- 003
- CZ-PrNML
- 005
- 20170908103931.0
- 007
- ta
- 008
- 170720s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/mbo3.345 $2 doi
- 035 __
- $a (PubMed)26987297
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Micenková, Lenka $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 245 10
- $a Microcin determinants are associated with B2 phylogroup of human fecal Escherichia coli isolates / $c L. Micenková, J. Bosák, B. Štaudová, D. Kohoutová, D. Čejková, V. Woznicová, M. Vrba, A. Ševčíková, J. Bureš, D. Šmajs,
- 520 9_
- $a Escherichia coli strains are classified into four main phylogenetic groups (A, B1, B2, and D) and strains of these phylogroups differ in a number of characteristics. This study tested whether human fecal E. coli isolates belonging to different phylogroups differ in prevalence of bacteriocinogenic isolates and prevalence of individual bacteriocinogenic determinants. A set of 1283 fecal E. coli isolates from patients with different diseases was tested for the presence of DNA regions allowing classification into E. coli phylogroups and for the ability to produce bacteriocins (23 colicins and 7 microcins). Of the isolates tested, the most common was phylogroup B2 (38.3%) followed by phylogroups A (28.3%), D (26.3%) and B1 (7.2%). Altogether, 695 bacteriocin producers were identified representing 54.2% of all tested isolates. The highest prevalence of bacteriocin producers was found in group B2 (60.3%) and the lowest in group B1 (44.6%). Determinants encoding colicins E1, Ia, and microcin mV were most common in phylogroup A, determinants encoding microcins mM and mH47 were most common in phylogroup B2, and determinant encoding mB17 was most common in phylogroup D. The highest prevalence of bacteriocinogeny was found in phylogroup B2, suggesting that bacteriocinogeny and especially the synthesis of microcins was associated with virulent and resident E. coli strains.
- 650 _2
- $a bakteriociny $x metabolismus $7 D001430
- 650 _2
- $a koliciny $x metabolismus $7 D003087
- 650 _2
- $a Escherichia coli $x klasifikace $x izolace a purifikace $x metabolismus $x patogenita $7 D004926
- 650 _2
- $a feces $x mikrobiologie $7 D005243
- 650 _2
- $a gastrointestinální trakt $x mikrobiologie $7 D041981
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a fylogeneze $7 D010802
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bosák, Juraj $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 700 1_
- $a Štaudová, Barbora $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 700 1_
- $a Kohoutová, Darina $u 2nd Department of Internal Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Sokolská 581, 500 05, Hradec Králové, Czech Republic.
- 700 1_
- $a Čejková, Darina $u Department of Immunology, Veterinary Research Institute, Hudcova 70, 621 00, Brno, Czech Republic.
- 700 1_
- $a Woznicová, Vladana $u Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekarˇská 53, 656 91, Brno, Czech Republic.
- 700 1_
- $a Vrba, Martin $u Department of Clinical Microbiology, Faculty Hospital Brno, Jihlavská 20, 625 00, Brno, Czech Republic.
- 700 1_
- $a Ševčíková, Alena $u Department of Clinical Microbiology, Faculty Hospital Brno, Jihlavská 20, 625 00, Brno, Czech Republic.
- 700 1_
- $a Bureš, Jan $u 2nd Department of Internal Medicine - Gastroenterology, Charles University in Prague, Faculty of Medicine at Hradec Králové, University Teaching Hospital, Sokolská 581, 500 05, Hradec Králové, Czech Republic.
- 700 1_
- $a Šmajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A6, 625 00, Brno, Czech Republic.
- 773 0_
- $w MED00184561 $t MicrobiologyOpen $x 2045-8827 $g Roč. 5, č. 3 (2016), s. 490-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26987297 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170908104531 $b ABA008
- 999 __
- $a ok $b bmc $g 1239796 $s 985028
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 5 $c 3 $d 490-8 $e 20160314 $i 2045-8827 $m MicrobiologyOpen $n Microbiologyopen $x MED00184561
- LZP __
- $a Pubmed-20170720